Dr. Xiaodan Wang, MD

Dr. Wang practices at Saint Annes Hospital Mri - Satellite - Mri - Primacare - HOPD in Fall River, Massachusetts.

Dr. Wang's NPI, 1134381163, was assigned on July 1, 2008. Dr. Wang holds Massachusetts license 250533.

Dr. Wang's primary practice is Saint Annes Hospital Mri - Satellite - Mri - Primacare - HOPD, at 289 Pleasant St, Fall River, MA 02721.

Dr. Wang's primary practice is Saint Annes Hospital Mri - Satellite - Mri - Primacare - HOPD in Fall River, Massachusetts. Dr. Wang is also affiliated with Charlton Memorial Hospital. The medical group on file is Prima Care. Dmand AI also links Dr. Wang to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Wang is licensed in Massachusetts.

CMS data shows 2,639 Medicare services from Dr. Wang across 11 procedure codes in 2024, for 1,004 Medicare patients. Medicare paid $215,539 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,004 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 70, with 47% women.

In 2024, Dr. Wang wrote 755 Medicare Part D claims for 360 patients. 90% of them were for generic drugs. CMS names the drug for 449 of them, across 20 drugs with 11 or more claims each, at $26,085 in total drug cost. In 2023, CMS named 281 claims across 15 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Wang, published from 2010 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Brain, Mice, Inbred C57BL and Neurons. Dr. Wang has published most often in Inorg Chem. Dr. Wang's most frequent co-authors are Michael G. Svestka, MD, Shanjin Cao, MD, PhD and Samuel Calvert Dudley, MD, PhD.

CMS Open Payments shows 68 general payments to Dr. Wang from 18 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $223.